Cetera Advisors LLC - SPDR SER TR ownership

SPDR SER TR's ticker is SPYV and the CUSIP is 78464A508. A total of 354 filers reported holding SPDR SER TR in Q4 2019. The put-call ratio across all filers is 0.05 and the average weighting 1.1%.

Quarter-by-quarter ownership
Cetera Advisors LLC ownership history of SPDR SER TR
ValueSharesWeighting
Q4 2023$8,478,221
+50.7%
181,819
+33.4%
0.12%
+33.0%
Q3 2023$5,624,615
-5.5%
136,321
-1.1%
0.09%
-6.4%
Q2 2023$5,954,652
-7.0%
137,839
-12.4%
0.09%
-12.1%
Q1 2023$6,405,229
-14.4%
157,299
-18.3%
0.11%
-21.3%
Q4 2022$7,483,999
+173.0%
192,440
+142.1%
0.14%
+88.9%
Q3 2022$2,741,000
+3.3%
79,475
+10.3%
0.07%
+20.0%
Q2 2022$2,653,000
-3.3%
72,057
+9.7%
0.06%
+9.1%
Q1 2022$2,743,000
+343.9%
65,705
+346.9%
0.06%
+323.1%
Q4 2021$618,000
+22.1%
14,703
+13.4%
0.01%
+30.0%
Q3 2021$506,000
+19.3%
12,965
+20.9%
0.01%0.0%
Q2 2021$424,000
+22.2%
10,726
+17.2%
0.01%0.0%
Q1 2021$347,000
+57.7%
9,149
+44.6%
0.01%
+11.1%
Q4 2019$220,000
-28.8%
6,328
-34.5%
0.01%
-35.7%
Q3 2019$309,000
+19.3%
9,661
+18.4%
0.01%
+16.7%
Q2 2019$259,000
-19.3%
8,158
-22.7%
0.01%
-25.0%
Q1 2019$321,000
+25.4%
10,552
+12.3%
0.02%
+6.7%
Q4 2018$256,000
-65.7%
9,399
-60.9%
0.02%
-59.5%
Q3 2018$747,000
-18.8%
24,055
-22.6%
0.04%
-30.2%
Q2 2018$920,000
+6.5%
31,088
+5.5%
0.05%
+1.9%
Q1 2018$864,000
+311.4%
29,454
+333.8%
0.05%
+300.0%
Q4 2017$210,0006,7890.01%
Other shareholders
SPDR SER TR shareholders Q4 2019
NameSharesValueWeighting ↓
Hamilton Capital, LLC 12,934,594$511,434,00049.38%
Weitzel Financial Services, Inc. 37,218,060$686,426,00024.16%
Freestate Advisors LLC 468,586$18,528,00020.94%
Choice Wealth Advisors, LLC 668,856$26,447,00019.00%
RESTON WEALTH MANAGEMENT LLC 914,020$36,140,00018.08%
NICOLET ADVISORY SERVICES, LLC 3,028,355$119,741,00015.62%
Compton Financial Group, LLC 897,722$35,496,00015.12%
Measured Wealth Private Client Group, LLC 1,149,470$45,450,00014.47%
Tennessee Valley Asset Management Partners 747,801$30,00014.22%
ERTS Wealth Advisors, LLC 1,287,537$50,909,00013.77%
View complete list of SPDR SER TR shareholders